Pharma’s Digital Directive: Not If, But How
Executive Summary
Data science and data analytics offer operational advantages throughout large organizations. And the pharma should approach digital technology pragmatically, first applying the tools to what it already does.
You may also be interested in...
New Novartis CDO Bodson Outlines Digital Health Ambitions
Joining the Novartis executive committee at the start of this week, newly appointed chief digital officer Bertrand Bodson reveals to Scrip how he sees digital health underpinninig the Swiss major’s future. Efforts at the company have already delivered a 10-15% reduction in patient enrolment times in pilot trials.
Novartis Teams With Pear Therapeutics In Neurological Digital Health Pact
Duo aims to get Pear's THRIVE digital therapeutic approved, and to develop a new application to treat MS patients, then seek validation in clinical studies.
Understanding How To Develop BTK Inhibitors In MS Is Evolving
Having a reversible BTK inhibitor in the multiple sclerosis armamentarium could be the best way to favorably impact the treatment landscape.